BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Suh KW, Kim JH, Kim YB, Kim J, Jeong S. Thymidylate synthase gene polymorphism as a prognostic factor for colon cancer. J Gastrointest Surg. 2005;9:336-342. [PMID: 15749593 DOI: 10.1016/j.gassur.2004.09.030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Hahnvajanawong C, Chaiyagool J, Seubwai W, Bhudhisawasdi V, Namwat N, Khuntikeo N, Sripa B, Pugkhem A, Tassaneeyakul W. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil. World J Gastroenterol 2012;18:3955-61. [PMID: 22912546 DOI: 10.3748/wjg.v18.i30.3955] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
2 Funke S, Brenner H, Chang-Claude J. Pharmacogenetics in colorectal cancer: a systematic review. Pharmacogenomics 2008;9:1079-99. [PMID: 18681783 DOI: 10.2217/14622416.9.8.1079] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
3 Panczyk M. Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years. World J Gastroenterol. 2014;20:9775-9827. [PMID: 25110414 DOI: 10.3748/wjg.v20.i29.9775] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 63] [Article Influence: 12.2] [Reference Citation Analysis]
4 Park CM, Lee WY, Chun HK, Cho YB, Yun HR, Heo JS, Yun SH, Kim HC. Relationship of polymorphism of the tandem repeat sequence in the thymidylate synthase gene and the survival of stage III colorectal cancer patients receiving adjuvant 5-flurouracil-based chemotherapy. J Surg Oncol. 2010;101:22-27. [PMID: 19798689 DOI: 10.1002/jso.21412] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
5 Suh KW, Kim JH, Kim do Y, Kim YB, Lee C, Choi S. Which gene is a dominant predictor of response during FOLFOX chemotherapy for the treatment of metastatic colorectal cancer, the MTHFR or XRCC1 gene? Ann Surg Oncol. 2006;13:1379-1385. [PMID: 17009149 DOI: 10.1245/s10434-006-9112-y] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
6 Bittoni A, Faloppi L, Giampieri R, Cascinu S. Selecting the best treatment for an individual patient. Recent Results Cancer Res. 2012;196:307-318. [PMID: 23129382 DOI: 10.1007/978-3-642-31629-6_20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
7 Yu KH, Wang WX, Ding YM, Li H, Wang ZS. Polymorphism of thymidylate synthase gene associated with its protein expression in human colon cancer. World J Gastroenterol. 2008;14:617-621. [PMID: 738222 DOI: 10.3748/wjg.14.617] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
8 Scartozzi M, Maccaroni E, Giampieri R, Pistelli M, Bittoni A, Del Prete M, Berardi R, Cascinu S. 5-Fluorouracil pharmacogenomics: still rocking after all these years? Pharmacogenomics. 2011;12:251-265. [PMID: 21332317 DOI: 10.2217/pgs.10.167] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
9 Okuno T, Tamura T, Yamamori M, Chayahara N, Yamada T, Miki I, Okamura N, Kadowaki Y, Shirasaka D, Aoyama N, Nakamura T, Okumura K, Azuma T, Kasuga M, Sakaeda T. Favorable genetic polymorphisms predictive of clinical outcome of chemoradiotherapy for stage II/III esophageal squamous cell carcinoma in Japanese. Am J Clin Oncol 2007;30:252-7. [PMID: 17551301 DOI: 10.1097/01.coc.0000256059.88247.25] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
10 Wang SL, Li X, Zhang S, Gui J, Huang DS. Tumor classification by combining PNN classifier ensemble with neighborhood rough set based gene reduction. Comput Biol Med 2010;40:179-89. [PMID: 20044083 DOI: 10.1016/j.compbiomed.2009.11.014] [Cited by in Crossref: 60] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
11 Sakaeda T, Yamamori M, Kuwahara A, Nishiguchi K. Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy. Adv Drug Deliv Rev 2009;61:388-401. [PMID: 19135108 DOI: 10.1016/j.addr.2008.10.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
12 Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast RC. ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer. JCO 2006;24:5313-27. [DOI: 10.1200/jco.2006.08.2644] [Cited by in Crossref: 960] [Cited by in F6Publishing: 434] [Article Influence: 64.0] [Reference Citation Analysis]
13 Vargas T, Moreno-Rubio J, Herranz J, Cejas P, Molina S, Mendiola M, Burgos E, Custodio AB, De Miguel M, Martín-Hernández R, Reglero G, Feliu J, Ramírez de Molina A. 3'UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients. PLoS One 2016;11:e0168423. [PMID: 27992526 DOI: 10.1371/journal.pone.0168423] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
14 Fariña-Sarasqueta A, Gosens MJ, Moerland E, van Lijnschoten I, Lemmens VE, Slooter GD, Rutten HJ, van den Brule AJ. TS gene polymorphisms are not good markers of response to 5-FU therapy in stage III colon cancer patients. Cell Oncol (Dordr) 2011;34:327-35. [PMID: 21630057 DOI: 10.1007/s13402-011-0030-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
15 Paré L, Marcuello E, Altés A, del Rio E, Sedano L, Barnadas A, Baiget M. Transcription factor-binding sites in the thymidylate synthase gene: predictors of outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin? Pharmacogenomics J 2008;8:315-20. [PMID: 17684476 DOI: 10.1038/sj.tpj.6500469] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
16 Hu-Lieskovan S, Vallbohmer D, Zhang W, Yang D, Pohl A, Labonte MJ, Grimminger PP, Hölscher AH, Semrau R, Arnold D, Dellas K, Debucquoy A, Haustermans K, Machiels JP, Sempoux C, Rödel C, Bracko M, Velenik V, Lenz HJ. EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients. Clin Cancer Res 2011;17:5161-9. [PMID: 21673069 DOI: 10.1158/1078-0432.CCR-10-2666] [Cited by in Crossref: 34] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
17 Bohanes P, LaBonte MJ, Winder T, Lenz HJ. Predictive molecular classifiers in colorectal cancer. Semin Oncol 2011;38:576-87. [PMID: 21810517 DOI: 10.1053/j.seminoncol.2011.05.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
18 Chen Y, Yi C, Liu L, Li B, Wang Y, Wang X. Thymidylate synthase expression and prognosis in colorectal cancer: a meta-analysis of colorectal cancer survival data. Int J Biol Markers. 2012;27:e203-e211. [PMID: 23015402 DOI: 10.5301/jbm.2012.9584] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
19 Kontos CK, Papadopoulos IN, Fragoulis EG, Scorilas A. Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma. Br J Cancer 2010;102:1384-90. [PMID: 20424616 DOI: 10.1038/sj.bjc.6605654] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
20 Mutch MG. Molecular profiling and risk stratification of adenocarcinoma of the colon. J Surg Oncol 2007;96:693-703. [PMID: 18081153 DOI: 10.1002/jso.20915] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
21 Hitre E, Budai B, Adleff V, Czeglédi F, Horváth Z, Gyergyay F, Lövey J, Kovács T, Orosz Z, Láng I, Kásler M, Kralovánszky J. Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil. Pharmacogenet Genomics 2005;15:723-30. [PMID: 16141798 DOI: 10.1097/01.fpc.0000175598.42141.59] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]